drugset / Trial / NCT01808378

Stem Cells Treatment for Bilateral Limbic Associated Keratopathy (HULPOFT)

NCT01808378 ↗

NaSingle-groupOpen-labelTreatment

Summary

Evaluate the use of the autologous ASC for the treatment of bilateral limbic associated keratopathy

Timeline

Start
2013-02
Primary completion
2013-12
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Expanded adipose-derived stem cells Cell therapy 400000 cells Other

Indications